Innovation

Inspiring Minds and Driving Equity: MSD’s 5th Hackathon

September 2025

The 5^th edition of the Health Equity hackathon, hosted by MSD’s LEAD (League of Employees of African Descent) UK Employee Business Resource Group (EBRG) network in collaboration with Eli Lilly’s embRACE, brought together curious undergraduates from across the country, to propose innovative solutions to health equity challenges.

Over 70 students from a range of academic and cultural backgrounds brought inspiring enthusiasm and fresh ideas to health equity challenges. They collaborated in small teams, with the support of a facilitator, to propose solutions to address disparities in health equity. Teams worked across 4 themes, including access to healthcare in older adults, the impact of mental health on outcomes, driving diversity in clinical trials and improving health literacy.

Group photo of Hackathon participants and colleagues from MSD and Lilly

After ‘hacking’ their problem statement, students presented solutions to senior leaders from both companies who served as judges. Despite an incredibly high standard, the judges managed to select winners from each theme. These groups then went on to present in the final round in front of a full auditorium, with Ben Lucas (Managing Director, MSD UK and Ireland) and Christopher Stokes (President and General Manager of Lilly, UK and Northern Europe) sitting on the panel as final round judges.

The winning solution won praise for being innovative, inclusive and patient-focused. It addressed the challenge of improving health literacy in underserved and ethnic minority communities to better understand, access, and use health information to achieve better outcomes. The winning team proposed connecting junior/resident doctors to young people aged 11-16 years old. Through creating this ‘Junior to Junior’ connection, their initiative aimed to increase awareness of the health system and build trust in communities.

Excerpt from the winning solution

Selfie with the winning team!

“I was genuinely impressed by the depth of insight and creativity the students brought to their solutions. Their work demonstrated by their strong technical skills and a deep understanding of social impact allowed for innovative, inclusive and patient-focused outcomes to be designed. The diverse, empathetic approaches to health equity and their ability to tackle complex challenges with passionate and energetic actionable ideas were standout qualities. Judging the event was a privilege and a powerful reminder of the value of fresh perspectives in addressing systemic health issues.”

– Jasveen Chugh, Pharmaceuticals Business Unit Director, MSD UK

In addition to raising awareness of the importance of health equity, across the 2-day event, students were also able to gain a real insight into what a career in the pharmaceutical industry can offer them. Through hearing from, and networking with, a range of colleagues from senior leaders to current placement students (some of whom took part in previous hackathons), they gained an understanding of the diversity of roles available for them to apply for.

Post-event networking session

Hackathon co-hosts Fiona Noah (MSD) and Paige Boateng (Lilly)

MSD is proud of the hackathon’s role in empowering and developing future leaders and forming a pipeline of diverse talent; by attending the hackathon, the participants and winning group will be accelerated through both MSD and Lilly’s early talent programme assessment stages.

Fiona Noah and Mauranda Lewis, Co-Lead’s of LEAD UK offered their reflections on the day:

‘As the leaders of LEAD UK, we’re really proud of how this year’s Health Equity Hackathon went. What stood out most was the students’ passion, drive, and tireless effort. Their creativity, determination, and dedication to tackling tough health equity challenges was inspiring and showed the future leaders and innovators in the making.

The quality of ideas, collaborative spirit, and innovative solutions shared throughout the day was truly impressive. It’s amazing to be able to contribute to an initiative that not only sparks innovation but also champions representation and access in healthcare’

Professional photos taken by Esther Akin

GB-NON-11910 | September 2025

Innovation

Sharing Learnings & Best Practice at NHS ConfedExpo

July 2025

MSD at NHS ConfedExpo 2025

NHS ConfedExpo 2025 provided a platform for healthcare leaders and innovators to come together to share learnings and best practices to shape the future of health and care in the UK. Over two days in Manchester, MSD engaged with key stakeholders to share insights, foster collaboration, and showcase how we are supporting the NHS in delivering cutting-edge, patient-centred solutions.

Our Role as a Sponsor

As a sponsor of this year’s NHS ConfedExpo, MSD colleagues showcased our partnership with the NHS through a dedicated stand that highlighted our collaborative efforts to save and improve lives.

MSD Sponsored Sessions: Driving Innovation and Patient-Centred Care

MSD was delighted to host two insightful sessions that sparked meaningful discussions around healthcare innovation and improving patient diagnosis and management:

Exploring Cancer Patient Experience in a Digital World

This session explored the transformative potential of the NHS’s shift from analogue to digital systems, with a focus on enhancing the cancer patient journey. Attendees examined how emerging technologies, including artificial intelligence (AI), can facilitate earlier cancer diagnoses, empower patient self-referrals, and streamline care pathways—ultimately improving patient experiences and outcomes. The discussion included examples of pilot projects within NHS trusts leveraging AI tools to reduce diagnostic delays.

Pathways to Progress: Optimising Diagnosis for Patients with Breathlessness

Breathlessness is a common symptom across conditions, yet it remains frequently under-recognised and poorly managed. MSD’s session highlighted the urgent need to improve diagnostic pathways through collaborative and innovative approaches. The discussion emphasised the importance of streamlined referral processes, enhanced access to diagnostics via Community Diagnostic Centres, and increased awareness of dedicated breathlessness pathways to reduce delays and improve patient outcomes. Aligning with national efforts to shift care from hospitals to community settings, the session underscored the critical role of strong clinical leadership and cross-sector collaboration in creating a more responsive, equitable healthcare system for patients living with breathlessness.

Watch Our Highlights Video

Discover the key insights and takeaways from NHS ConfedExpo 2025 by watching our highlights video on the MSD UK LinkedIn page. Click here to watch.

Learn More

To find out more about MSD’s partnerships and our ongoing initiatives to support healthcare innovation, visit our Partnerships page.

GB-NON-11721 | July 2025

Innovation

MSD to acquire Verona Pharma

July 2025

In a strategic move that strengthens our innovative pipeline of cardio-pulmonary treatments, MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) today announced it has entered into a definitive agreement to acquire, through a subsidiary, Verona Pharma, a UK-based biopharmaceutical company specialising in respiratory diseases.

Under the terms of the agreement, MSD will acquire Verona Pharma for $107 per American Depositary Share (ADS)—each representing eight ordinary shares—bringing the total transaction value to approximately $10 billion.

This acquisition aligns with MSD’s science-led business development strategy and reinforces its commitment to addressing unmet medical needs in cardio-pulmonary care.

“This acquisition of Verona Pharma reflects the commitment we have to delivering innovative treatments to patients and our ability to execute on our science-led and value-driven business development strategy,” said Robert M. Davis, chairman and chief executive officer, MSD.

“Today’s announced agreement with MSD is the culmination of years of focus and determination by the Verona Pharma team,” said David Zaccardelli, president and chief executive officer, Verona Pharma. “We believe MSD’s commercial footprint and industry-leading clinical capabilities will help accelerate the potential of Verona Pharma to reach more patients. This agreement will enable the strong launch trajectory of our portfolio of medicines and provides value to Verona Pharma shareholders.”

The transaction was unanimously approved by both the MSD and Verona Pharma Boards of Directors and is intended to be effected by way of a scheme of arrangement under UK law. Closing of the proposed acquisition is subject to approval under the Hart-Scott-Rodino Antitrust Improvements Act, approval of Verona Pharma shareholders, sanction by the High Court of Justice of England and Wales and other customary conditions. The transaction is expected to close in the fourth quarter of 2025.

GB-NON-11649 | July 2025

Responsibility

Solutions for Healthy Communities: new grant round open

February 2025

We believe local organisations and leaders know their communities best, and we are eager to support such organizations to improve access to health for underserved communities around the globe.

The Solutions for Health Communities global grant programme aims to advance access to healthcare for underserved communities through innovative, community-led solutions.

Detailed information about the application process, eligibility criteria, and funding priorities can be found on our website at: MSD.com/SHC, or by clicking the button below.

Learn More

The deadline for applications is 28^th February 2025 and projects will run from January 2026 through December 2027.

UK applicants with queries, please contact grantscommittee@msd.com.

GB-NON-11019 | February 2025

Our People

Employee volunteering – many ways to make a difference

August 2024

All year round our employees take part in a full range of volunteering experiences, from refereeing at swimming events, to painting walls, or mentoring young people.

All MSD employees are given 40 hours of volunteering time to support a cause they feel passionate about. Every effort counts and individuals have found many ways to make a unique positive impact.

Refereeing at the swimming British Championships

MSD Sales Manager, Adrian, has been volunteering every year for the past twelve years at swimming events across the country. After his daughters started competing in the sport, Adrian become involved in the swimming events. He is now proud to be one of the few referees from a diverse background and that the volunteering policy allows him to pursue this passion. Through his commitment, he has now progressed to become a referee and receives invitations to events across the country, including the Olympic trials in London.

One of his most cherished moments from his volunteering experience is when he was asked to present the medals at the end of the British Championships. To Adrian’s surprise, he had the incredible opportunity to present a medal to his own daughter!

Brightening up community spaces

The ALIANZA UK team recently put their volunteering hours to fantastic use by supporting the Latin American House charity! Our MSD volunteers embarked on a two-day project to paint the office areas of the Latin American House Community Hub, specifically the Brazil and Colombia rooms.

Despite the scorching hot weather, the team did a great job and found it incredibly rewarding to the see the transformation. The ALIANZA UK team contributed to creating a more welcoming and vibrant environment for staff, clients and visitors.

Keeping history alive

One of our employees has found immense joy in utilising her volunteering hours at The American Museum in Bath, a museum of American art and culture surrounded by beautiful gardens.

Working in the herb shop, MSD Sales Manager, Janet, collects herbs from the garden to create Tussie Mussies, a colonial American item to sell to visitors. She volunteers regularly and has started taking her daughter along to volunteer with her!

Being one of the four Americans working at the museum, Janet also appreciates the chance to have conversations with a variety of people about her home country, its history and culture. Volunteering has not only provided her with a connection to her home country but has had a positive impact on her mental wellbeing and Janet encourages others to explore volunteering opportunities available to them!

Mentoring for positive change

Vicky dedicates one hour a week to Motivation, Commitment and Resilience (MCR) Pathways, a national mentoring programme that aims to make a meaningful difference to the lives of young people. Volunteering for one-hour a week during the school term, she consistently provides positive support to teenagers facing various challenges.

Vicky underwent training before being matched with her mentee, ensuring she had the necessary skills for the role, with the programme striving to pair mentors with mentees who share similar interests to create meaningful connections.

She claims ‘At first, I was nervous and wasn’t sure what I had to offer but I believe we all have the necessary skills to simply be there for a young person. All they need is someone to be interested in them.’

Our employees have a number of team initiatives also under way including a donation drive and volunteering at the Whitechapel Mission Charity this coming autumn.

The diverse volunteering experiences of our MSD employees exemplify the variety of ways to make a positive impact. These stories illustrate that regardless of the form it takes, volunteering allows individuals to connect to their passions, make a difference and creative positive change in their communities and beyond.

GB-NON-09983 | August 2024

Partnerships

MSD highlights progress on addressing health inequalities in cancer in England

May 2024

How can we learn from the work of Cancer Alliances in reducing health inequalities at a local level?

MSD in the UK have published the report, Driving health equity in cancer: Practical examples from Cancer Alliances, demonstrating the progress Cancer Alliances in England are making towards addressing health inequalities.

The publication, Driving health equity in cancer: Practical examples from Cancer Alliances, brings together a collection of case studies of local projects within Cancer Alliances across the country that aim to overcome the health inequalities in cancer care and outcomes in their area. It highlights practical steps that can be taken, such as working with organisations in the local community, to reach underserved or hard-to-reach populations – who are often more at risk of certain cancer types but don’t readily engage with the health system.

Bringing together practical examples in this way is intended to inspire cancer services and local communities to think differently about the opportunities available to support populations impacted by health inequalities by showcasing steps that can be taken to support them and extend and improve their lives.

Read the report

The project was funded and led by MSD in the UK, working with Cancer Alliances to bring together case studies of the crucial work they have been undertaking over the course of many years.

We are grateful to NHS England National Healthcare Inequalities Improvement Programme Directors and to Macmillan Cancer Support for their endorsement for this project – providing feedback and forewords for the publication:

Professor Peter Johnson, National Clinical Director for Cancer, and Professor Bola Owolabi, Director of the National Healthcare Inequalities Improvement Programme, said:

“The case studies in this report showcase the innovative and responsive ways in which we hoped that Cancer Alliances and other organisations would implement the Core20PLUS5 programme – in their local communities, shaping their work around the community’s specific needs. We have enjoyed hearing about these case studies throughout the project and hope they inspire others, as they have inspired us, to continue our life-saving and important work in addressing health inequalities in cancer across England.”

Claire Taylor MBE, Chief Nursing Officer, and Professor Richard Simcock, Chief Medical Officer, at Macmillan Cancer Support, said:

“Eliminating health inequalities is becoming an increasing priority in the UK as we continue to see widening variation in cancer outcomes. This report offers positive and practical ways to improve health equity with useful insights from others’ key learnings and also further resources you may wish to access.”

Health inequalities have a direct impact on the risk of getting cancer, the speed with which someone is diagnosed, and their likelihood of surviving – MSD’s October 2022 report, Levelling up: what does it mean for the less survivable cancers in England?, analysed national data from some of the least survivable cancers and found that only 49% of people living in the most deprived quintile are diagnosed with cancer at an early stage (stage 1 or 2), compared to 58% of people from the least deprived quintile.¹

It is vital that the Government and NHS continue to focus on tackling inequalities to achieve the early diagnosis and survival ambitions set out in the NHS Long Term Plan.²

Benson Fayehun, MSD UK Oncology Business Unit Head

“Addressing health inequalities is deeply personal to me and is one of the biggest barriers we face to improving the nation’s health. National commitments and leadership help set the tone and direction – but it is through learning from, and innovating with, communities on the ground that we see the action needed to bring about positive change and improve people’s lives.

We are delighted to have been able to bring together some of the fantastic and inspiring work that Cancer Alliances have undertaken in partnership with local charities and community organisations to overcome cultural, physical or logistical barriers to equal healthcare. By sharing these positive examples we hope to inspire others within the health system, local authorities, charities and community groups to think differently about their roles in addressing health inequalities and the opportunities that there are to support their local populations.”

Examples of the fantastic projects Cancer Alliances have been delivering, include:

The Alright Me Liver? campaign in Somerset, Wiltshire, Avon & Gloucestershire to improve early detection of liver cancer – one of the less survivable cancers – in deprived communities, who have an increased risk of death from liver cancer.³

This Van Can is a mobile health clinic targeting groups at higher risk of prostate cancer in Greater Manchester.
You Need to Know campaign in Northeast London to tackle low awareness of womb cancer, where incidence and mortality rates are higher in people of non-white ethnicities and from more deprived communities.^4,5
Efforts in Southeast London to ensure patients with learning difficulties receive optimal care

[1] MSD, Levelling up: what does it mean for the less survivable cancers in England?, September 2022, job number: GB-NON-06239. Available: https://www.msd-uk.com/wp-content/uploads/sites/43/2022/10/Levelling-up_What-does-it-mean-for-the-less-survivable-cancers-in-England.pdf

[2] NHS England (2019). NHS long term plan: chapter three: cancer. Available: https://www.longtermplan.nhs.uk/online-version/chapter-3-further-progress-on-care-quality-and-outcomes/better-care-for-major-health-conditions/cancer/#:~:text=This%20Long%20Term%20Plan%20sets,least%20five%20years%20after%20diagnosis. Accessed April 2024

[3] Mayor of Bristol (2023). Alright my liver? Liver cancer awareness month. Available: https://thebristolmayor.com/2023/10/01/alright-my-liver/ Accessed JApril 2024.

[4] Cancer Research UK, Uterine cancer statistics. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer#heading-Zero Accessed April 2024.

[5] Cancer Research UK, Uterine cancer statistics,. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer#heading-Zero Accessed April 2024

GB-NON-09360 | May 2024

Responsibility

MSD for Mothers Reaches 30 Million Women Worldwide

May 2024

MSD has announced that MSD for Mothers has reached more than 30 million women through programs promoting safe, high-quality and respectful maternal health care – surpassing its goal of reaching 25 million women by 2025.

MSD for Mothers is dedicated to finding solutions to end maternal mortality with over 200 programs in more than 70 countries designed to deliver on the unique maternal health needs of women around the world.

While the maternal health landscape has experienced progress in recent years, maternal mortality remains a reality for too many. According to the World Health Organization, a maternal death occurred nearly every two minutes in 2020, with almost 95% occurring in low-income or lower middle-income countries. Through MSD for Mothers, the company upholds its commitment to expanding access to health and accelerating progress toward one of the United Nations’ Sustainable Development Goal targets: to reduce the global maternal mortality ratio to less than 70 per 100,000 live births by 2030.

To advance this ambition, MSD for Mothers works closely with various public and private sector collaborators to strengthen health systems for the long-term and address the diverse needs of moms, babies and families globally.

“I am so proud of our company’s long-standing commitment to our MSD for Mothers initiative, which is dedicated to improving maternal health outcomes around the world,” said Allison Goldberg, president of our company’s foundation. “Through MSD for Mothers, we have now helped more than 30 million women access high-quality, life-saving care around pregnancy and childbirth – surpassing our goal of reaching 25 million women by 2025. This milestone serves as a reminder that much work is left to be done, and we remain committed to helping create a world where no woman has to die while giving life.”

To learn more about this milestone achievement, read the company’s full announcement here.

GB-NON-09434 | May 2024

Responsibility

Shining a light on our work in Diversity, Equity, and Inclusion

March 2024

MSD’s Chief Diversity Officer, Celeste Warren, strives to ensure that our policies and practices provide an equal opportunity for all so that our workforce reflects the diversity of the world. This she says “enables us to better understand the needs of the patients, health care providers and customers we serve,”

And that means embedding a culture of diversity, equity and inclusion at every level of the organisation, a commitment that’s central to our business growth as well as to our employees’ well-being.

At MSD in the UK, our work is more than just scientific: we recognise that we have an important part to play in tackling health disparities to drive improvements in healthcare access and outcomes for patients across the UK.

We believe in creating a more equitable and inclusive society where everyone has the best chance of staying healthy and well, regardless of their background, identity and circumstances.

Diversity, Equity and Inclusion (DEI) are at the centre of everything we do and is part of our ways of working. Our employees with shared experiences and their allies come together as Employee Business Resource Groups (EBRG’s). Providing a community and informing change across our business, our EBRGs help everyone at MSD bring their authentic selves to work, and ultimately champion and drive improvements externally in our mission to save and improve lives.

Prioritising diversity and inclusion benefits employees and our business

We’ve made a lot of progress on our diversity and inclusion efforts in our workplace, including:

- Strong membership growth across our 10 EBRGs globally with approximately 21,500 employees who belong to EBRGs, and many of our UK employees are active participants.
- Launch of an internal Ally Resource Centre to provide access to resources and educational materials to support each employee’s D&I learning journey.
- Development of an integrated disability inclusion strategy to create a disability-confident workplace culture where people with disabilities feel accepted, connected and can fully contribute.
- An annual UK Health Equity hackathon, hosted by our LEAD network (League of Employees of African Descent) in collaboration with Eli Lilly’s embRACE brings together over 55 undergraduate students from a range of diverse academic and cultural backgrounds, inviting curious minds to ‘hack’ the problem of health equity, explore potential solutions, and network. As well an increasing awareness of health equity, the event contributes to a pipeline of diverse talent as the winning group are accelerated through the early talent programme assessments.
- Our UK EBRG’s have recently driven the implementation of a new ‘Transitioning At Work’ policy, a new ‘Menopause Policy’ and a mandatory ‘Sexual Harassment’ training programme for all employees
- MSD is proud to be a member of the Patient Information Forum (PIF) and are part of their Trusted Information Creator accreditation scheme (the PIF TICK) – the UK’s only quality mark for health information. We commit that our public-facing materials are produced in line with PIF’s criteria, ensuring that our information is accessible and accurate.

We are on a journey, and are proud to be shining a light on our work so far. Watch our video and follow our stories on social media over the coming weeks.

GB-NON-09023 | February 2024

Partnerships

Eliminating cervical cancer across the UK could save £2.6 billion, new research finds

January 2024

The UK could save £2.6 billion by achieving the WHO global targets for cervical cancer by 2046, landmark new research reveals.

An estimated 3,200 cases of cervical cancer are diagnosed in the UK every year – nine women every day. 99.8% of cervical cancer cases in the UK are caused by HPV, which means that nearly every case of cervical cancer is preventable[i].

Under its global call to action towards elimination, the WHO has set a target incidence of 4 cases of cervical cancer per 100,000 women, to be achieved by countries ensuring that 90% of girls receive human papillomavirus (HPV) vaccination by age 15, 70% of women access cervical screening aged 35 and 45, and 90% of women with pre-cancer and invasive cancer are appropriately treated and managed[ii]. According to the new report – undertaken by OHE and fully funded by MSD – the UK is anticipated to hit these targets by 2046, which would lead to a 23% reduction in the socioeconomic burden of cervical cancer between 2023 and 2046.

The new research comes soon after NHS England’s November announcement that it would be pursuing the elimination of cervical cancer by 2040, noting the potential to save thousands of lives [iii]. And the NHS Vaccination Strategy published in December puts England one step closer to elimination through a range of commitments to improve HPV vaccination coverage rates[iv].

But progress is not guaranteed and there is still a long road to elimination: the latest vaccine coverage data for the routine school-aged HPV immunisation programme in England for the 2022/23 academic year shows that whilst have been some gains, coverage is still behind that recorded pre-COVID-19 pandemic [v].

The report authors call on governments in Scotland, Wales and Northern Ireland to follow England’s lead in pledging to eliminate cervical cancer by 2040 – thereby accelerating the path to elimination across the UK and ensuring equality and consistency in the approach to elimination between the four nations.

To download a copy of the report, click here.

Ben Lucas, Managing Director, MSD UK & Ireland, who commissioned the research, said:

“At MSD, we are dedicated to inspiring country-wide action towards elimination by showcasing the success of areas already hitting WHO targets at the local and national levels. The OHE’s findings on the socioeconomic benefits of eliminating cervical cancer add even more impetus to the race to elimination, but we cannot forget the huge personal impact of this mission. The OHE rightly note the critical importance of overcoming existing inequalities in access to HPV vaccination and cervical screening if we are to make a success of elimination, and I am delighted to see the report set out recommendations on how elimination might work for every part of society.”

[i] Cancer Research UK, Cervical cancer statistics. Last accessed December 2023, available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer#heading-Zero

[ii] World Health Organization, Cervical Cancer Elimination Initiative. Last accessed December 2023, Available from: https://www.who.int/initiatives/cervical-cancer-elimination-initiative

[iii] NHS England, NHS sets ambition to eliminate cervical cancer by 2040, 15 November 2023. Last accessed December 2023, available from: https://www.england.nhs.uk/2023/11/nhs-sets-ambition-to-eliminate-cervical-cancer-by-2040/

[iv] NHS England, NHS Vaccination Strategy, December 2023. Last accessed December 2023, available from: https://www.england.nhs.uk/long-read/nhs-vaccination-strategy/

[v] UK Health Security Agency, Official Statistics: Human papillomavirus (HPV) vaccination coverage in adolescents in England: 2022 to 2023. Last accessed January 2023, available from: https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2022-to-2023

GB-NON-08825 | January 2024

Responsibility

MSD labs awarded certification for sustainable science

December 2023

After a thorough assessment of our equipment, practices, and products, MSD’s LBIC and Crick labs have been certified by My Green Lab.

For our LBIC site, we received the highest level, which is Green, and for the Crick we received Platinum which is the second highest level.

Recognised by the United Nations Race to Zero campaign as a key measure of progress towards a zero-carbon future, My Green Lab Certification is considered the gold standard for laboratory sustainability best practices around the world.

My Green Lab Certification is a proven, scalable program that helps organisations achieve their sustainability goals. It offers tried-and-true methods rooted in science to dramatically reduce the environmental impact of laboratories without disrupting the critical work underway.

Mehriban Akin, Safety and Environment Lead for MSD Research Labs (MRL) in the UK said:

“As we work toward a greener future, we are considering the impact of our scientific operations and striving to undertake our research sustainably to support the health of our planet and its people. Every step counts to make our labs more sustainable and we are committed to doing all that we can to make real and impactful changes to decrease the environmental footprint of our research.”

More information about the program can be found at www.mygreenlab.org/green-lab-certification

GB-NON-08730 | December 2023

Inspiring Minds and Driving Equity: MSD’s 5th Hackathon

Sharing Learnings & Best Practice at NHS ConfedExpo

MSD at NHS ConfedExpo 2025

MSD to acquire Verona Pharma

Solutions for Healthy Communities: new grant round open

We believe local organisations and leaders know their communities best, and we are eager to support such organizations to improve access to health for underserved communities around the globe.

Employee volunteering – many ways to make a difference

MSD highlights progress on addressing health inequalities in cancer in England

Benson Fayehun, MSD UK Oncology Business Unit Head

MSD for Mothers Reaches 30 Million Women Worldwide

Shining a light on our work in Diversity, Equity, and Inclusion

Prioritising diversity and inclusion benefits employees and our business

Eliminating cervical cancer across the UK could save £2.6 billion, new research finds

MSD labs awarded certification for sustainable science

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA